Back to Search
SUSAN COLLA, D.O.
D.O.
Family Medicine Physician
NPI: 1316194079Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
005349(AZ)
Research & Publications (20)
Bumblebee vulnerability: common correlates of winners and losers across three continents.
PMID 19245487·Conserv Biol·2009
7-preclinical
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target.
PMID 18474725·Blood·2008
7-preclinical
CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
PMID 18703490·Cancer Res·2008
4-observational
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
PMID 17105813·Blood·2007
8-other
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells.
PMID 17255354·Blood·2007
8-other
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.
PMID 17848618·Blood·2007
8-other
CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.
PMID 17303695·Blood·2007
8-other
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival.
PMID 17082008·Haematologica·2006
4-observational
Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients.
PMID 16401825·Blood·2006
8-other
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients.
PMID 16208410·Leukemia·2005
8-other
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.
PMID 15933061·Blood·2005
8-other
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma.
PMID 15878977·Blood·2005
7-preclinical
Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression and functional production by human multiple myeloma cells.
PMID 15710592·Haematologica·2005
8-other
Update on the pathogenesis of osteolysis in multiple myeloma patients.
PMID 15796087·Acta Biomed·2004
6-review
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
PMID 15377473·Haematologica·2004
8-other
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL).
PMID 15308315·Exp Hematol·2004
6-review
e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
PMID 15136228·Haematologica·2004
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3551 ROGER BROOKE DR DEPT OF
FORT SAM HOUSTON, TX 78234 - Phone
- (210) 916-4141
Quick Facts
- NPI
- 1316194079
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile